Emerging pharmaceutical companies face a crucial challenge in today’s data-driven landscape. While established firms are making strides in leveraging big data, many new entrants still grapple with the complexities of data analytics. This gap can hinder their ability to capitalize on the wealth of information available, from patient claims to electronic health records.
The Analytics Gap
The 2019 Emerging Pharma Pulse Report reveals a concerning trend: nearly 60% of emerging pharma companies engage with advanced analytics only to a limited extent. This approach is insufficient for crafting effective commercial strategies essential for maximizing a new therapy’s market presence. To thrive, these companies must adopt a comprehensive data strategy that integrates advanced computing tools.
Harnessing Advanced Techniques
With the right data and computational resources, emerging pharma can utilize sophisticated methodologies like machine learning to extract valuable insights. The first step involves mastering the capabilities of advanced analytics and effectively incorporating these insights into their commercial frameworks. This integration is not merely an option but a necessity to remain competitive in the evolving landscape.
Overcoming Data Management Challenges
Processing vast volumes of data presents a significant hurdle for emerging companies. Many face difficulties in organizing and storing data, making it challenging to perform advanced analytics. A recent survey highlighted data organization as one of the top concerns for these firms. Successfully embedding advanced analytics into commercial operations mandates a dedicated effort from commercial teams to build models, interpret data, and stay updated on analytical advancements.
The Imperative of Commitment
Companies that neglect to prioritize advanced analytics risk falling behind their competitors. While traditional analytics may offer basic insights for product commercialization, advanced analytics empowers teams to develop finely tuned strategies. By leveraging robust analytics, companies can gain valuable information regarding the patient journey and prescriber behavior, enhancing all aspects of their commercial approach.
Foundations of a Strong Data Management Strategy
Before diving into advanced analytics, emerging pharma must establish a solid data management strategy. This strategy should focus on three key elements:
- Data Expertise: The complexity of healthcare data necessitates skilled professionals who can navigate its nuances and ensure proper organization.
- Cloud Computing Access: To handle large datasets efficiently, companies should invest in cloud computing resources. The cloud not only facilitates data processing but also provides real-time access to updated analyses, alleviating the burdens of traditional on-premise solutions.
-
Designated Leadership: With limited resources, companies often struggle to prioritize data management. Appointing an internal champion to lead data strategy development can ensure that analytics remains a central focus.
Transforming Sales Forecasting
Sales forecasting is fundamental to an effective commercial strategy. Advanced analytics can refine this process by providing deeper insights into market potential. By uncovering essential data points, such as the target patient population and optimal physician engagement frequency, companies can create informed forecasts that align with effective sales force deployment.
Dynamic Customer Targeting
Emerging pharma companies can leverage advanced analytics to enhance their customer targeting strategies. Traditional methods rely on static target lists updated infrequently. However, machine learning enables dynamic targeting, allowing teams to quickly adapt to new data and changing market conditions. This agility can significantly improve the effectiveness of sales and marketing efforts.
Improving Incentive Compensation Strategies
Retention of top sales representatives is a persistent challenge, with many companies reporting high turnover rates. To address this, emerging pharma must develop motivating incentive compensation structures informed by advanced analytics. By simulating outcomes and understanding the impact of sales activities, companies can transition from commission-based to quota-based plans effectively, ensuring sustainability and engagement.
Understanding the Patient Journey
Advanced analytics equips commercial teams with insights into the patient journey across various treatment pathways. By aggregating data on individual patients, teams can identify segments and tailor their strategies. For instance, predictive analytics can reveal patient cohorts with specific insurance challenges, allowing sales reps to prioritize discussions about assistance programs during physician visits.
Identifying Market Opportunities
For products lacking extensive market data, analyzing the patient journey can uncover potential market segments. By examining claims data, commercial teams can identify patients likely to benefit from their offering. Targeting physicians who treat these patients can facilitate broader adoption and inform strategic decisions about sales force alignment.
The Path Forward
The potential of advanced analytics is undeniable, yet emerging pharma companies risk squandering these opportunities without proactive planning. To harness the benefits of data analytics, firms must invest in robust data management strategies and advanced computing tools. By doing so, they can unlock insights that inform precise commercial tactics and maintain a competitive edge in the evolving pharmaceutical landscape.
In conclusion, the race for advanced analytics is not just about technology; it’s about strategy and foresight. Companies that embrace this challenge today will be well-positioned to thrive tomorrow, navigating the complexities of the healthcare landscape with agility and insight.
- Emphasize the importance of integrating advanced analytics into commercial strategies.
- Invest in cloud computing and data expertise to manage complex datasets efficiently.
- Appoint internal champions to prioritize data management and governance.
- Utilize predictive analytics to enhance customer targeting and sales strategies.
- Continuously refine incentive compensation plans based on analytical insights.
Source: www.pharmexec.com
